CSI Market
Sign In | Register

Acceleron Pharma inc (XLRN) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access XLRN Annual Income Statement →
This income statement overview for Acceleron Pharma inc spans from Sep 30 2020 to Sep 30 2021, showing how the company's revenues, expenses, and earnings have changed across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2021)
Q3 2021 		(Jun 30 2021) (Mar 31 2021) (Dec 31 2020) (Sep 30 2020)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax34.20
Total Revenue34.20
Costs & Expenses
Gross Profit34.20
Selling, Administration, Marketing45.11
Depreciation & Amortization0.00
Research and Development Expense59.72
Other Operating Expense / -Income0.00
Total operating costs including COS104.83
Operating income / -loss-70.63
Interest Income0.00
Net Interest (-)Expense / Income0.00
Other loss / -income-0.18
Total costs & expenses104.65
Income & Taxes
Income / -loss before income taxes-70.45
Income taxes expenses / -benefit0.02
Income after income taxes-70.47
Net income / -loss of other equity0.00
Income / -loss from continuing operations-70.47
Net income / -loss-70.47
Income / -loss to shareholder-70.47
EBIT-70.45
EBITD-69.29
EBITDA-69.29
Earnings Per Share
Basic EPS (excl. extra items)-1.16
Basic Net EPS-1.16
Basic shares outstanding (Mill. of Units)60.94
Diluted Net EPS-1.16
Diluted average shares (Mill. of Units)60.94
4 historic quarters locked

Sign in to unlock the full Acceleron Pharma inc income statement history.

Sign In Create Free Account

About XLRN Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.